Pulmatrix

Pulmatrix is a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment, prevention, and control of infectious and progressive respiratory diseases. It provides inhaled cationic airway lining modulators that stimulate host defense mechanisms within the airways to treat and prevent influenza, rhinovirus, and chronic lung diseases. The company was founded in 2003 and is headquartered in Lexington, Massachusetts.